申请人:Millennium Pharmaceuticals, Inc.
公开号:US20040157861A1
公开(公告)日:2004-08-12
This invention provides compounds that are inhibitors of the TGF-&bgr; signaling pathway. The compounds are represented by formula I:
1
where A′ is N or CH; Ring B is preferably an triazolyl, imidazolyl, or thiazolyl ring; —X-D- is a linker group; and G is an optionally substituted aryl or heteroaryl ring. The compounds are useful for treating cardiovascular disease.
该发明提供了一些抑制TGF-&bgr;信号通路的化合物。这些化合物由公式I表示:其中A'是N或CH;环B最好是三唑基、咪唑基或噻唑基环;—X-D-是连接基团;G是可选的取代芳基或杂环基。这些化合物可用于治疗心血管疾病。